Correlation Between Dupont De and Xbrane Biopharma
Can any of the company-specific risk be diversified away by investing in both Dupont De and Xbrane Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Xbrane Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Xbrane Biopharma AB, you can compare the effects of market volatilities on Dupont De and Xbrane Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Xbrane Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Xbrane Biopharma.
Diversification Opportunities for Dupont De and Xbrane Biopharma
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Dupont and Xbrane is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Xbrane Biopharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xbrane Biopharma and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Xbrane Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xbrane Biopharma has no effect on the direction of Dupont De i.e., Dupont De and Xbrane Biopharma go up and down completely randomly.
Pair Corralation between Dupont De and Xbrane Biopharma
Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.09 times more return on investment than Xbrane Biopharma. However, Dupont De Nemours is 10.79 times less risky than Xbrane Biopharma. It trades about 0.06 of its potential returns per unit of risk. Xbrane Biopharma AB is currently generating about -0.01 per unit of risk. If you would invest 6,818 in Dupont De Nemours on September 1, 2024 and sell it today you would earn a total of 1,541 from holding Dupont De Nemours or generate 22.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 98.9% |
| Values | Daily Returns |
Dupont De Nemours vs. Xbrane Biopharma AB
Performance |
| Timeline |
| Dupont De Nemours |
| Xbrane Biopharma |
Dupont De and Xbrane Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Xbrane Biopharma
The main advantage of trading using opposite Dupont De and Xbrane Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Xbrane Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xbrane Biopharma will offset losses from the drop in Xbrane Biopharma's long position.| Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide | Dupont De vs. LyondellBasell Industries NV |
| Xbrane Biopharma vs. Kancera AB | Xbrane Biopharma vs. Cyxone AB | Xbrane Biopharma vs. Lidds AB | Xbrane Biopharma vs. Cantargia AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |